ProCE Banner Activity

Complicated Clinical Infections: Clinical Impact of New Data From ECCMID 2023

Podcast Episodes

Hear from David van Duin, MD, PhD, FIDSA, FAST, on the latest data on complicated clinical infections presented at ECCMID 2023, including current and future therapies for multidrug-resistant gram-negative infections and antimicrobial stewardship strategies for bacteremia and ventilator-associated pneumonia.

Released: May 03, 2023

Share

Faculty

David Van Duin

David Van Duin, MD, PhD, FIDSA, FAST

Professor of Medicine
Director, Immunocompromised Host Infectious Diseases Program
Division of Infectious Diseases
University of North Carolina
Chapel Hill, North Carolina

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Shionogi Inc.

Shionogi Inc

Disclosure

Primary Author

David Van Duin, MD, PhD, FIDSA, FAST

Professor of Medicine
Director, Immunocompromised Host Infectious Diseases Program
Division of Infectious Diseases
University of North Carolina
Chapel Hill, North Carolina

David van Duin, MD, PhD, FIDSA, FAST: consultant/advisor/speaker: Entasis, Merck, Pfizer, Qpex, Roche, Shionogi, Union, Utility; researcher: Merck, Shionogi.